Dashboard
Manage Tickers

SMMTSummit Therapeutics Inc.

Nasdaq summittxinc.com


$ 24.14 $ -0.94 (-3.73 %)    

Thursday, 19-Sep-2024 10:14:02 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 482.58 $ -0.11 (-0.02 %)
DIA $ 420.67 $ -1.26 (-0.3 %)
SPY $ 570.10 $ -0.94 (-0.16 %)
TLT $ 99.06 $ 0.14 (0.14 %)
GLD $ 237.81 $ -0.44 (-0.18 %)
$ 24.56
$ 25.08
-- x --
$ 24.15 x 100
$ 25.08 - $ 25.08
$ 1.64 - $ 33.89
8,142,119
na
17.79B
$ -0.24
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-06-2024 06-30-2024 10-Q
2 05-01-2024 03-31-2024 10-Q
3 02-20-2024 12-31-2023 10-K
4 11-07-2023 09-30-2023 10-Q
5 08-09-2023 06-30-2023 10-Q
6 05-11-2023 03-31-2023 10-Q
7 03-09-2023 12-31-2022 10-K
8 11-09-2022 09-30-2022 10-Q
9 08-11-2022 06-30-2022 10-Q
10 05-11-2022 03-31-2022 10-Q
11 03-17-2022 12-31-2021 10-K
12 11-15-2021 09-30-2021 10-Q
13 08-12-2021 06-30-2021 10-Q
14 05-17-2021 03-31-2021 10-Q
15 03-31-2021 12-31-2020 10-K
16 11-16-2020 09-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

merckdaiichi-sankyo-partnered-lung-cancer-candidate-meets-primary-goal-in-late-stage-study
Merck/Daiichi Sankyo Partnered Lung Cancer...
09/17/2024 11:58:10

Merck reported topline data from its HERTHENA-Lung02 phase 3 trial of patritumab deruxtecan in EGFR-mutated non-small cell lung...

hc-wainwright--co-reiterates-buy-on-summit-therapeutics-maintains-45-price-target
HC Wainwright & Co. Reiterates Buy on Summ...
09/17/2024 11:34:30

HC Wainwright & Co. analyst Mitchell Kapoor reiterates Summit Therapeutics (NASDAQ:SMMT) with a Buy and maintains $45 pr...

alphabet-to-200-here-are-10-top-analyst-forecasts-for-monday
Alphabet To $200? Here Are 10 Top Analyst ...
09/16/2024 12:35:34

summit-therapeutics-shares-are-trading-higher-after-the-company-announced-hat-data-for-the-novel-potential-first-in-class-investigational-bispecific-antibody-ivonescimab-was-presented-at-the-2024-esmo-annual-meeting
Summit Therapeutics shares are trading hig...
09/16/2024 12:18:56

hc-wainwright--co-maintains-buy-on-summit-therapeutics-raises-price-target-to-45
HC Wainwright & Co. Maintains Buy on Summi...
09/16/2024 10:51:16

HC Wainwright & Co. analyst Mitchell Kapoor maintains Summit Therapeutics (NASDAQ:SMMT) with a Buy and raises the price ...

summit-therapeutics-says-ivonescimab-data-were-presented-at-2024-esmo-annual-meeting-including-two-presentations-and-one-poster-featuring-updated-ivonescimab-data-in-advanced-triple-negative-breast-cancer-recurrentmetastatic-head-and-neck-squamous-cell-carcinoma-and-metastatic-microsatellite-stable-colorectal-cancer
Summit Therapeutics Says Ivonescimab Data ...
09/16/2024 10:32:18

Core News & Articles
Chewy, Broadcom And MicroStrategy Are Amon...
09/15/2024 15:48:51

These ten stocks saw significant gains last week, with Summit Therapeutics up 98.32% and BioNTech up 31.77%. Analysts also rais...

heres-how-much-100-invested-in-summit-therapeutics-5-years-ago-would-be-worth-today
Here's How Much $100 Invested In Summit Th...
09/13/2024 15:31:02

signet-jewelers-posts-better-than-expected-earnings-joins-netgear-lovesac-and-other-big-stocks-moving-higher-on-thursday
Signet Jewelers Posts Better-Than-Expected...
09/12/2024 14:45:13

why-summit-therapeutics-smmt-stock-is-rising-today
Why Summit Therapeutics (SMMT) Stock Is Ri...
09/12/2024 13:15:25

Summit Therapeutics shares are trading higher by 5.1% Thursday morning. The company announced it raised $235 million in net pro...

summit-therapeutics-says-accepted-offers-from-multiple-investors-to-purchase-aggregate-of-1035m-shares-at-2270-per-share-for-aggregate-gross-proceeds-of-235m
Summit Therapeutics Says Accepted Offers F...
09/12/2024 10:36:21

All of Summit's Section 16 officers participated in the capital raise. A total of $79 million was raised by insiders, inclu...

summit-therapeutics-options-trading-a-deep-dive-into-market-sentiment
Summit Therapeutics Options Trading: A Dee...
09/11/2024 15:45:51

citigroup-maintains-buy-on-summit-therapeutics-raises-price-target-to-19
Citigroup Maintains Buy on Summit Therapeu...
09/09/2024 15:25:03

Citigroup analyst Yigal Nochomovitz maintains Summit Therapeutics (NASDAQ:SMMT) with a Buy and raises the price target from ...

terns-pharmaceuticals-boeing-tesla-and-other-big-stocks-moving-higher-on-monday
Terns Pharmaceuticals, Boeing, Tesla And O...
09/09/2024 14:13:07

stifel-maintains-buy-on-summit-therapeutics-raises-price-target-to-25
Stifel Maintains Buy on Summit Therapeutic...
09/09/2024 14:12:22

Stifel analyst Bradley Canino maintains Summit Therapeutics (NASDAQ:SMMT) with a Buy and raises the price target from $14 to...

starbucks-to-rally-around-21-here-are-10-top-analyst-forecasts-for-monday
Starbucks To Rally Around 21%? Here Are 10...
09/09/2024 13:05:16

Core News & Articles
Market-Moving News for September 9th
09/09/2024 12:09:37

PLTR: 8% | Palantir Technologies shares are trading higher amid its addition to the S&P 500 index. TERN: 42% | Terns Pharma...

summit-therapeutics-lung-cancer-candidate-surpasses-mercks-multi-billion-dollar-keytruda-cuts-risk-of-disease-or-death-by-half
Summit Therapeutics' Lung Cancer Candidate...
09/09/2024 12:02:45

Summit Therapeutics shared Phase 3 HARMONi-2 trial data of ivonescimab, showing significant improvement in progression-free sur...

hc-wainwright--co-maintains-buy-on-summit-therapeutics-raises-price-target-to-30
HC Wainwright & Co. Maintains Buy on Summi...
09/09/2024 10:37:53

HC Wainwright & Co. analyst Mitchell Kapoor maintains Summit Therapeutics (NASDAQ:SMMT) with a Buy and raises the price ...

why-summit-therapeutics-shares-are-trading-higher-by-around-18-here-are-20-stocks-moving-premarket
Why Summit Therapeutics Shares Are Trading...
09/09/2024 10:08:36

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION